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Abstract 
 
It is usually assumed that the higher dietary exposure to substances (in mg/kg bw) in young 
individuals compared to adults is the resultant of a relatively high consumption needed for 
growth. When this relatively high exposure of young individuals temporarily exceeds the 
human limit value, the assessment of possible health risks is not straightforward. The aim of 
this study was to find a way of scaling exposure in order to reduce the effect of age on the 
dietary intake. Several (allometric) scaling approaches were applied to explore their impact on 
age-related intake patterns. It was demonstrated that allometric scaling reduces the effect of 
body weight. Nevertheless, the results indicate that the higher exposure in young individuals 
is not only the resultant of a relatively high consumption needed for growth, but still contains 
influences of body weight. Therefore the conclusion was drawn that a different scaling of 
dietary exposure is not expedient. It is advised that, when a human limit value is exceeded for 
a relatively short period, the characteristics (e.g. accumulating properties) of the compound 
and the design of the toxicological studies informing the human limit value are examined 
closely to assess the health risk. 
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Introduction 
 
In toxicology it is assumed that the response to chemical exposure is a function of the amount 
of the compound a species (animal or human) encounters. The impact of a given amount of a 
chemical on an individual partly depends on his body size, with larger absolute amounts 
usually being necessary to achieve the same response in species with larger body sizes. This 
dependence on the body size is taken into account by scaling dose to body mass, i.e. 
expressing dose in mg/kg bw/day. Consequently, a human limit value (e.g. ADI, TDI, RfD) 
derived from such a dose is expressed in the same unit. To enable the comparison of the 
exposures and a human limit value the exposure should also be expressed scaled 
proportionally, i.e. isometric, to body weight, e.g. expressed in mg/kg bw1.0.  
 
In practice, it is often noted that within the same species infant and juvenile individuals have a 
higher dietary exposure to chemical substances when expressed per kg body weight compared 
to adult individuals (e.g. Bakker et al., 2008; Boon et al., 2008, and figures 2 and 3 in the 
results section). It is usually assumed that the higher exposure (in mg/kg bw1.0) in young 
individuals is the resultant of a relatively high consumption needed for growth. When the 
relatively high exposure of young individuals temporarily exceeds the human limit value, the 
assessment of possible health risks is therefore not straightforward (see the report of the Food 
and Consumer Product Safety Authority (VWA, 2008)). Hence, it would be expedient to 
express dietary exposure to substances in such manner that it will become independent of age. 
In that case, it is less likely that exposure exceeds the human limit value for a relative short 
period during youth. Consequently, risk assessment of dietary exposure expressed in this way 
will become less complicated. The aim of the present study is therefore to find a way of 
scaling exposure that renders the dietary intake of substances independent of age. 
 
From inter- and intraspecies studies in the fields of toxicology and pharmacology it is known 
that dose-scaling to body weight other than proportional, i.e. allometric scaling, is more 
appropriate than isometric scaling. Based on empirical findings and theoretical arguments 
three scaling approaches are generally advocated: scaling to bw0.67, bw0.7, and bw0.75 (Baird et 
al., 1996; Bokkers and Slob, 2007; Chappell, 1989; Mahmood, 1999; Rhomberg, 2002, 2004; 
Rhomberg and Lewandowski, 2006; Schneider et al., 2004; Travis and White, 1988; 
Watanabe et al., 1992; West et al., 1997, 1999).  
In this report we will investigate how much the effect of body weight on the intake of 
substances via food can be reduced by using allometric instead of isometric scaling. The 
dietary exposure to the brominated flame retardant 2,2’,4,4’-brominated diphenyl ether (BDE-
47) and the heavy metal cadmium from food are used to illustrate the various scaling 
approaches. 
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Methods 
 
Consumption data 
Consumption data were collected in the third Dutch National Food Consumption Survey 
(DNFCS-3) conducted in 1997–1998, as described in detail by Kistemaker et al. (1998). 
Briefly, 6250 individuals, aged 1 to 97 years, from 2564 households were selected. 
Respondents recorded their food consumption over two consecutive days. Furthermore, 
DNFCS-3 contains the body weights of all individuals (Figure 1). The data of individuals 
aged 1 to 80 years were used, because the data of ages 80+ are too few to derive reliable 
results. 
 
Figure 1. Body weight (kg) plotted against age (years). The dots indicate the individual values of men 
and women from DNCF-3. Trend line is obtained with PROAST v20.21 using the likelihood ratio test 
(Slob, 2002). 
 
 
Concentration data  
The concentration data of 2,2’,4,4’-brominated diphenyl ether (BDE-47) are obtained from 
Bakker et al. (2008). Because of its lipophilicity and widespread environmental distribution, 
BDE-47 is found in various, mainly lipid rich, foods. A summary of the concentration data is 
provided in Table 1. The reader is referred to Bakker et al. (2008) for further details on the 
concentration data. 
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Table 1. Mean concentrations of BDE-47 (pg/g product or pg/g fat) in food groups 
sampled in the year 2004. Data are from Bakker et al. (2008). 
 
Food group Fat (%) 
Concentration 
(*pg/g product or 
**pg/g fat) 
Fatty fish  NA 1725 * 
Bread 1 10 * 
Pork  26 142 ** 
Eggs  10 220 ** 
Crustaceans  NA 455 * 
Vegetables 0 4 * 
Cheese  31 209 ** 
Fruit 0 4 * 
Beef  16 113 ** 
Poultry  9 181 ** 
Butter  81 13 ** 
Lean fish  NA 171 * 
Vegetable oils 57 10 * 
Industrial oils 35 15 * 
Milk  1 2010 ** 
   NA = Not available 
 
 
For cadmium the same concentration data were used as applied by Boon et al. (2010) who 
updated the dataset analyzed by de Winter et al. (2003). These data were obtained from the 
Quality Agricultural Products Database, which were derived from monitoring programs 
performed in the Netherlands by the Dutch Food and Consumer Product Safety Authority 
(VWA) and the Dutch Dairy Association from 1999 up to 2007. The reader is referred to 
Boon et al. (2010) and de Winter et al. (2003) for a description of the approach to convert 
concentrations in raw agricultural commodities to concentrations in food products, to handle 
of non-detects, and to derive concentrations in meat. An overview of the resulting mean 
cadmium concentrations per food group is presented in Table 2. Levels per food are reported 
are reported by Boon et al. (2010). 
 
 
Table 2. Mean cadmium concentration per food group. Data are from Boon 
et al. (2010)  
 
Food group 
 
Concentration 
(µg/g product) 
Cereals 0.040 
Potatoes 0.023 
Vegetables 0.028 
Meat 0.066 
Fruit 0.009 
Fish, shellfish and crustaceans 0.042 
Honey 0.006 
 
 
All daily consumptions were multiplied with the (mean) concentration of the substance per 
consumed food and summed over foods consumed per day per individual. This resulted in a 
distribution of daily exposures. The estimated exposures are expressed in various ways: 
absolute, scaled to bw, bw0.67, bw0.7, or bw0.75. 
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A distribution of daily exposures includes both the variation between individuals and between 
the two days of one individual. However, to assess the long-term intake within a population 
only the within-person variation is of interest, since in the long run fluctuations in daily 
concentrations are assumed to average out. Therefore, the within-person (between days) 
variation should first be removed from the distribution of daily exposures using statistical 
modeling. 
Here we use the betabinomial-normal (BBN) model (de Boer et al., 2009; Slob, 2006), which 
allows for derivation of the exposure distribution as a function of age. The often reported 50th 
and 95th percentiles (P50 and P95) of the exposure distributions are reported. Exposures were 
derived using MCRA, version 6.2 (de Boer and van der Voet, 2007). 
 
 
 
 
 
 
 
 
 
Results 
 
Figure 2 shows the intake of BDE-47 by men (dashed line) and women (solid line) scaled in 
various ways as a function of age. The plots on the left represent the P50 (median) of the 
exposure, and the plots on the right show the P95 of the exposure for the same body weigth-
scaling approach. In general, it can be noted that the exposure shows the same pattern over the 
ages when comparing the P50 and P95. In Figure 2A and 2B the absolute exposure is given, 
i.e. no measures are applied to normalize the exposure. Here men have a higher exposure 
compared to women due to their higher intake of foods containing BDE-47. In both sexes the 
absolute exposure increases during the first 20 years of life. From age 20 to 80 the absolute 
exposure increases slightly. Figures 2C and 2D present the exposure as scaled to body weight 
(i.e. bw1.0). The scaled exposures are similar in men and women. In both sexes the exposure 
decreases during the first 20 years of life, and is similar between ages 20 and 80. In Figures 
2E and 2F, 2G and 2H, and 2I and 2J the daily exposures are presented after allometric 
scaling to body weight, i.e. to bw0.67, bw0.7, and bw0.75, respectively. After allometric scaling 
the exposure shows a similar pattern as the isometrically scaled exposure. 
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Figure 2. The exposure to BDE-47 for men (dashed line) and women (solid line) as a function of age. 
The graphs on the left represent the P50 (median) of the exposure, and the plots on the right show the 
P95 of the exposure for the same scaling approach: 2A and 2B: the absolute exposure (ng/day), 2C and 
2D, 2E and 2F, 2G and 2H, and 2I and 2J: exposure scaled to bw1.0, bw0.67, bw0.7, and bw0.75, 
respectively. 
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Figure 2 continued. 
 
 
 
Figure 3 shows the intake of cadmium by men (dashed line) and women (solid line) scaled in 
various ways as a function of age. Similar to BDE-47 it can be noted that the cadmium 
exposure shows a similar pattern over the ages when comparing the P50 and P95. In Figure 
3A and 3B the absolute exposure is given, i.e. no measures are applied to normalize the 
exposure. Here men have a higher (absolute) exposure compared to women due to their 
higher intake of foods containing cadmium. In both sexes the absolute exposure increases 
during the first 20 years of life. From age 20 to 80 the absolute exposure stays approximately 
the same. Figures 3C and 3D present the exposure as scaled to body weight (i.e. bw1.0). The 
scaled exposures are similar between men and women. In both sexes the exposure decreases 
during the first 20 years of life, and is similar in ages 20 to 80. In Figures 3E to 3J the daily 
exposures are presented after allometric scaling to body weight, i.e. to bw0.67, bw0.7, and 
bw0.75. After allometric scaling the exposure shows a similar pattern as the isometrically 
scaled exposure. 
 
In Table 3 the P50 exposures to BDE-47 and cadmium at ages 1 and 40 are given. The ratio of 
these exposure values illustrates the attribution of growth to the exposure at young age. In 
theory, in absence of growth the scaling approach should result in a ratio equal to 1, i.e. the 
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plot of the scaled exposure against age is a horizontal line. The ratio between the exposure at 
young and older ages decreases when allometric scaling is applied. 
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Figure 3. The exposure to cadmium for men (dashed line) and women (solid line) as a function of age. 
The graphs on the left represent the median (P50) of the exposure, and the plots on the right show the 
P95 of the exposure for the same scaling approach: 3A and 3B: the absolute exposure (µg/day), 3C and 
3D, 3E and 3F, 3G and 3H, and 3I and 3J: exposure scaled to bw1.0, bw0.67, bw0.7, and bw0.75, 
respectively. 
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Figure 3 continued. 
 
 
 
Table 3. Exposures to BDE-47 and cadmium at age 1 and 40 and the ratio thereof for the various 
scaling approaches. 
BDE-47 cadmium 
exposurea at age exposurea at age scaling sex 
1 40 ratio 
 
1 40 ratio 
male 2.0 0.4 4.6  0.44 0.15 2.9 bw1.0 female 1.8 0.4 4.6  0.40 0.14 2.9 
male 3.8 1.3 2.9  5.3 12.0 2.3 bw0.75 female 3.4 1.2 2.9  4.3 9.7 2.3 
male 4.3 1.6 2.7  0.92 0.57 1.6 bw0.7 female 3.8 1.4 2.7  0.81 0.50 1.6 
male 4.6 1.8 2.6  0.98 0.63 1.6 bw0.67 female 4.0 1.5 2.6  0.86 0.55 1.6 
a
 P50 in ng/day and scaled according to the first column 
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Discussion 
 
In this study several approaches to scale the exposure are applied to explore their impact on 
age-related intake patterns. Scaling powers lower than 0.67 were not applied because 
toxicological and pharmacological studies indicate that the scaling power should be around 
0.7. The ratio of the exposure values at ages 1 to 40 are derived for each scaling approach. 
The ratio between intakes of children and adults in using isometric scaling is a factor of about 
3-5. Allometric scaling reduces this factor by about 50 %. This indicates that the higher 
exposure (in mg/kg bw1.0) in young individuals is not only the resultant of a relatively high 
consumption needed for growth, but still contains influences of body weight. Allometric 
scaling removes or at least reduces the effect of body weight. However, after applying each of 
the assessed scaling approaches there is still a relatively high exposure at young ages, which 
can be attributed to growth. Therefore, it can be concluded that allometric scaling does not 
completely reduce the difference in exposure in children and adults. 
  
An important issue to take into account is the route of exposure applied in the toxicological 
studies. Human limit values are generally derived from animal studies. In an animal feed 
study the dosing regime is similar to long-term human exposure pattern, i.e. at young ages the 
exposure is relatively high compared to the exposure at adulthood. See for example Figure 6, 
where the doses of several long-term toxicity studies are plotted against the age of the animals 
after exposure via their feed. The effect(s) found in the animal (feed) study are a resultant of 
repeated exposure. When the animal is considered as a good surrogate to assess effects in 
humans, then similar effects can be expected in humans after relatively high doses at 
childhood and lower doses at adulthood. The effects found in a feed study in adult animals 
can be directly linked to the dose (in mg/kg bw), because exposure levels at adulthood include 
prior (higher) exposure at young ages (Luijckx et al., 1994). Assuming that the animal and 
human life stages are proportionally of similar duration, it is not needed to derive life-long 
average exposures when the human limit value is based on a feed study. The above reasoning 
only holds when the test compound is administered at a constant concentration in feed or 
water, and not when exposure is by gavage or via another route of exposure than oral, e.g. 
inhalation, dermal, intervenous, intraperitoneal. This is also recognized in the report of the 
Panel on Children and Chemical Substances of the Dutch Food and Consumer Products 
Safety Authority (VWA, 2008). 
 
Accumulating compounds pose another challenge when determining the proper exposure 
metric. It should be noted that the two example compounds addressed here, BDE-47 and 
cadmium are in fact accumulating compounds. For those compounds the accumulated 
concentration in the whole body (also known as body burden) or in a particular target organ is 
probably a more precise measure of exposure compared to the actual external exposure 
(Bakker et al., 2008; JECFA, 2002). Whole body or organ concentrations can be derived 
when (toxico)kinetic data are available and the (external) exposures are available in sufficient 
detail. Preferably, as a function of age (de Boer et al., 2009; Slob, 1993, 2006). 
 
Altogether, it is advised that, when a human limit value is exceeded at lower ages only, the 
characteristics (e.g. accumulating properties) of the compound and the setup of the 
toxicological studies informing the human limit value are examined closely to assess the risks 
for human health. 
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Figure 6. The dose (mg/kg bw1.0/day) for male (dashed line) and female (solid line) rats and mice as a 
function of time on the study (weeks). Animals are exposure via their feed. Data are from four random 
NTP technical reports (NTP, 1996, 2001a, b, 2004). 
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